Free · 2 imports included
code🏥 Medical Physiology and Pharmacology ├── 📖 Chapter 1: Renal Physiology and Pharmacology │ ├── 🔹 Proximal Convoluted Tubule Function │ ├── 🔹 Diuretics Acting on the Proximal Convoluted Tubule │ ├── 🔹 Fanconi Syndrome │ ├── 🔹 Loop Diuretics and the Thick Ascending Limb │ ├── 🔹 Bartter and Gitelman Syndromes │ ├── 🔹 Thiazide Diuretics and the Distal Convoluted Tubule │ └── 🔹 Potassium-Sparing Diuretics and the Collecting Duct ├── 📖 Chapter 2: Endocrine System Pharmacology │ ├── 🔹 Cholinergic and Adrenergic Receptors │ └── 🔹 GFR Arteriolar Regulation ├── 📖 Chapter 3: Cardiovascular System Review │ ├── 🔹 Heart Sounds and Cardiac Dysfunction │ ├── 🔹 Cardiomyopathies │ ├── 🔹 Valvular Diseases │ ├── 🔹 Congenital Heart Defects │ └── 🔹 Cardiac Arrhythmias and AV Blocks └── 📖 Chapter 4: Cardiovascular Pharmacology ├── 🔹 Antihypertensive Medications └── 🔹 Medications for Heart Failure
What this chapter covers: This chapter provides a detailed overview of renal physiology, focusing on the function of different segments of the nephron and the mechanisms of reabsorption and secretion. It also covers the pharmacology of diuretics, including their mechanisms of action and effects on electrolyte balance. This chapter is crucial for understanding the pathophysiology of various renal disorders and the rationale for diuretic therapy.
| Concept/Term | Definition/Description | Clinical Significance | Key Points |
|---|---|---|---|
| Proximal Convoluted Tubule (PCT) | Primary site for reabsorption in the nephron. | Defective function leads to Fanconi syndrome. | Contains Na/H antiporters, SGLT, AQP1 channels. |
| Acetazolamide | Carbonic anhydrase inhibitor acting on the PCT. | Used to treat glaucoma and prevent kidney stones. | Increases excretion of NaHCO3, K+, and NaCl. Contraindicated in cirrhosis. |
| Fanconi Syndrome | Defective sodium influx and impaired ATP production in the PCT. | Results in glucosuria, phosphaturia, uricosuria, and aminoaciduria. | Can be genetic (cystinosis, Wilson's disease) or acquired (heavy metals, drugs). |
| Loop Diuretics | Inhibit the NKCC2 transporter in the thick ascending limb. | Increase excretion of Na+, K+, 2Cl-, Ca2+, and Mg2+. | Furosemide, bumetanide, torsemide, ethacrynic acid. Can cause ototoxicity. |
| Bartter Syndrome | Mimics loop diuretics due to defects in NKCC2, ROMK, ClC-Kb, or BSND. | Causes salt wasting, volume depletion, hypokalemia, metabolic alkalosis. | Hypercalciuria can lead to nephrocalcinosis. |
| Gitelman Syndrome | Mimics thiazide diuretics due to inactivation of SLC12A3 (NCC). | Causes hypomagnesemia, hypocalcuria, hypokalemia, and alkalosis. | Increased renin and aldosterone. |
| Thiazide Diuretics | Inhibit the Na/Cl cotransporter (NCC) in the distal convoluted tubule (DCT). | Increase excretion of Na, K, H, and decrease calcium. | Chlorthalidone, indapamide, metolazone. Can cause hypercalciuria, hyperglycemia. |
| Potassium-Sparing Diuretics | Act on the collecting duct. | Increase sodium excretion and decrease potassium and hydrogen excretion. | Aldosterone antagonists (spironolactone, eplerenone), ENaC inhibitors (amiloride, triamterene). |
Question: A 35-year-old male presents with muscle weakness, fatigue, and polyuria. Lab results show hypokalemia, metabolic alkalosis, and normal blood pressure. Urine calcium levels are elevated. Which of the following is the most likely diagnosis? A) Gitelman syndrome B) Bartter syndrome C) Liddle syndrome D) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Answer: B Explanation: Bartter syndrome mimics the effects of loop diuretics, leading to hypokalemia, metabolic alkalosis, and hypercalciuria. Gitelman syndrome typically presents with hypocalciuria. Liddle syndrome causes hypertension. SIADH causes hyponatremia.
❌ Mistake 1: Confusing Bartter and Gitelman syndromes. ✅ How to avoid: Remember that Bartter syndrome mimics loop diuretics and causes hypercalciuria, while Gitelman syndrome mimics thiazide diuretics and causes hypocalciuria.
❌ Mistake 2: Forgetting the contraindications of acetazolamide. ✅ How to avoid: Remember that acetazolamide is contraindicated in cirrhosis due to the risk of hepatic encephalopathy.
Use a table to compare and contrast the different types of diuretics, including their mechanisms of action, effects on electrolyte balance, and clinical uses.
What this chapter covers: This chapter focuses on the pharmacology related to the endocrine system. It covers the mechanisms of action and clinical uses of various medications targeting hypertension, heart failure, and other cardiovascular conditions.
| Concept/Term | Definition/Description | Clinical Significance | Key Points |
|---|---|---|---|
| Cholinergic Receptors (M1/M3) | Gq-coupled receptors activated by acetylcholine. | Increase calcium levels via the PLC -> IP3 pathway. | Found in various tissues, including smooth muscle and glands. |
| Adrenergic Receptors (Alpha-1) | Gq-coupled receptors activated by norepinephrine and epinephrine. | Increase calcium levels and cause vasoconstriction. | Found in blood vessels and smooth muscle. |
| Adrenergic Receptors (Alpha-2) | Gi-coupled receptors activated by norepinephrine and epinephrine. | Inhibit norepinephrine release and decrease cAMP. | Found in presynaptic nerve terminals. |
| Adrenergic Receptors (Beta-1) | Gs-coupled receptors activated by norepinephrine and epinephrine. | Increase cAMP in the heart, leading to increased heart rate and contractility. | Found primarily in the heart. |
| Adrenergic Receptors (Beta-2) | Gs-coupled receptors activated by epinephrine. | Increase cAMP in smooth muscle, causing relaxation. | Found in smooth muscle of bronchioles and blood vessels. |
| GFR Regulation: Afferent Arteriolar Constriction (NSAIDs) | Decreases RPF, PGC, and GFR. | Can lead to acute kidney injury in susceptible individuals. | NSAIDs inhibit prostaglandin synthesis, causing vasoconstriction. |
| GFR Regulation: Afferent Arteriolar Dilation (PGAs) | Increases RPF, PGC, and GFR. | Compensatory mechanism to maintain GFR in certain conditions. | PGAs promote vasodilation. |
| GFR Regulation: Efferent Arteriolar Constriction (AII) | Decreases RPF and increases PGC, GFR, and FF. | Maintains GFR in states of low blood pressure or volume depletion. | Angiotensin II constricts the efferent arteriole. |
| GFR Regulation: Efferent Arteriolar Dilation (ACEi) | Increases RPF and decreases PGC, GFR, and FF. | Used to treat hypertension and proteinuria. | ACE inhibitors block the production of angiotensin II. |
| ADH (Vasopressin) | Acts on the distal convoluted tubule and collecting duct via V2 receptors. | Increases cAMP and activates PKA, leading to AQP2 insertion and increased water reabsorption. | Used to treat diabetes insipidus. |
Question: A 60-year-old male with hypertension is started on an ACE inhibitor. Which of the following effects on renal hemodynamics is most likely to occur? A) Increased RPF and increased GFR B) Decreased RPF and decreased GFR C) Increased RPF and decreased GFR D) Decreased RPF and increased GFR
Answer: C Explanation: ACE inhibitors block the production of angiotensin II, leading to efferent arteriolar dilation. This increases RPF and decreases PGC, GFR, and FF.
❌ Mistake 1: Confusing the effects of afferent and efferent arteriolar constriction on GFR. ✅ How to avoid: Remember that afferent constriction decreases GFR, while efferent constriction initially increases GFR (but prolonged constriction can decrease it).
❌ Mistake 2: Forgetting the effects of NSAIDs on renal hemodynamics. ✅ How to avoid: Remember that NSAIDs inhibit prostaglandin synthesis, leading to afferent arteriolar constriction and decreased GFR.
Draw diagrams illustrating the effects of different agents on renal hemodynamics, including RPF, PGC, GFR, and FF.
What this chapter covers: This chapter provides a review of cardiovascular physiology and pathology, including topics such as heart sounds, cardiomyopathies, valvular diseases, and congenital heart defects.
| Concept/Term | Definition/Description | Clinical Significance | Key Points |
|---|---|---|---|
| S1 Heart Sound | Closure of mitral and tricuspid valves. | Marks the beginning of systole. | Louder at the apex. |
| S2 Heart Sound | Closure of aortic and pulmonic valves. | Marks the end of systole. | Louder at the base. |
| S3 Heart Sound | Rapid ventricular filling in dilated ventricles. | Associated with heart failure. | "Kentucky" cadence. |
| S4 Heart Sound | Atrial contraction into stiff ventricles. | Associated with ventricular hypertrophy or diastolic dysfunction. | "Tennessee" cadence. |
| HFrEF (Heart Failure with Reduced Ejection Fraction) | Decreased SV, EF, and ESPVR; increased ESV, EDV, LVEDP, and PCWP. | Systolic dysfunction. | Reduced contractility. |
| HFpEF (Heart Failure with Preserved Ejection Fraction) | Decreased EDV and SV; highly increased EDP. | Diastolic dysfunction. | Impaired relaxation. |
| Dilated Cardiomyopathy (DCM) | Enlargement of all cardiac chambers. | Can be caused by mutations in TTN, thiamine deficiency, or drugs. | Leads to systolic dysfunction. |
| Hypertrophic Cardiomyopathy (HCM) | Autosomal dominant; mutations in beta-myosin heavy chain. | Systolic anterior motion (SAM) of the mitral valve. | Can cause sudden cardiac death. |
| Aortic Stenosis (AS) | Narrowing of the aortic valve. | Can be caused by senile calcific AS, bicuspid aortic valve, or RHD. | Leads to increased afterload on the left ventricle. |
| Mitral Regurgitation (MR) | Backflow of blood from the left ventricle into the left atrium. | Can be caused by chronic mitral valve prolapse or papillary muscle rupture. | Leads to increased preload on the left ventricle. |
| Atrial Septal Defect (ASD) | Hole in the atrial septum. | Causes a fixed, widely split S2. | Can lead to paradoxical embolism. |
| Ventricular Septal Defect (VSD) | Hole in the ventricular septum. | Causes a high-pitched holosystolic murmur. | Can lead to pulmonary hypertension. |
| Tetralogy of Fallot | Pulmonary stenosis, RVH, overriding aorta, and VSD. | Causes cyanosis. | Requires surgical correction. |
Question: A 70-year-old male presents with shortness of breath and fatigue. On auscultation, a loud S3 heart sound is heard. Which of the following is the most likely underlying condition? A) Aortic stenosis B) Mitral regurgitation C) Heart failure with reduced ejection fraction D) Hypertrophic cardiomyopathy
Answer: C Explanation: An S3 heart sound is associated with rapid ventricular filling in dilated ventricles, which is a characteristic finding in heart failure with reduced ejection fraction.
❌ Mistake 1: Confusing S3 and S4 heart sounds. ✅ How to avoid: Remember that S3 is associated with dilated ventricles and heart failure, while S4 is associated with stiff ventricles and ventricular hypertrophy.
❌ Mistake 2: Forgetting the components of Tetralogy of Fallot. ✅ How to avoid: Use the mnemonic "PROVe": Pulmonary stenosis, RVH, Overriding aorta, VSD.
Listen to heart sounds recordings to familiarize yourself with the different sounds and their associated conditions.
Create a free account to import and read the full study notes — all 5 sections.
No credit card · 2 free imports included